Melissa A Price

US Patent:

20060160805, Jul 20, 2006

Filed:

May 27, 2004

Appl. No.:

10/857321

Inventors:

Robert Ternansky - San Diego CA, US
Patricia Gladstone - San Diego CA, US
Amy Allan - San Diego CA, US
Melissa Price - Cardiff CA, US
Andrew Mazar - San Diego CA, US

International Classification:

A61K 31/537
A61K 31/44
A61K 31/4164
A61K 31/425
A61K 31/40
A61K 31/407
A61K 31/14

US Classification:

514237500, 514358000, 514372000, 514396000, 514357000, 514408000, 514411000, 514642000, 514643000, 544170000, 546329000, 546347000, 548212000, 548335100, 548428000, 564282000, 564292000

Abstract:

The current invention provides novel thiotungstate derivatives, methods of making novel thiotungstate derivatives, pharmaceutical compositions of novel thiotungstate derivatives, methods of using novel thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders and obesity and methods of using pharmaceutical compositions of thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation.

US Patent:

20110151022, Jun 23, 2011

Filed:

Dec 13, 2010

Appl. No.:

12/966516

Inventors:

Robert J. Ternansky - San Diego CA, US
Patricia L. Gladstone - San Diego CA, US
Amy L. Allan - Encinitas CA, US
Melissa L.P. Price - Cardiff CA, US
Andrew P. Mazar - San Diego CA, US

International Classification:

A61K 33/30
C07F 11/00
A61K 31/28
A61K 31/555
A61P 3/04
A61P 35/00
A61P 19/02

US Classification:

424643, 556 57, 514492, 546 5, 514188, 548403, 548104

Abstract:

The current invention provides novel thiotungstate derivatives, methods of making novel thiotungstate derivatives, pharmaceutical compositions of novel thiotungstate derivatives, methods of using novel thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders and obesity and methods of using pharmaceutical compositions of thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation.

US Patent:

20040019087, Jan 29, 2004

Filed:

May 28, 2003

Appl. No.:

10/447585

Inventors:

Robert Ternansky - San Diego CA, US
Andrew Mazar - San Diego CA, US
Patricia Gladstone - San Diego CA, US
Dimitri Coucouvanis - Ann Arbor MI, US
Amy Allan - Encinitas CA, US
Sean O'Hare - San Diego CA, US
Melissa Price - Cardiff CA, US
Fernando Donate - San Diego CA, US

International Classification:

A61K031/44
A61K031/14
C07D207/46

US Classification:

514/357000, 514/408000, 514/642000, 514/643000, 546/329000, 548/566000, 564/281000, 564/282000

Abstract:

The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF- B dysregulation and methods of using pharmaceutical compositions of thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF- B dysregulation.

Address:

15518 Dracena Ave, Moorpark, CA 93021

Phone:

805 551-9799

VIN:

JH4CU2F61CC009462

Make:

ACURA

Model:

TSX

Year:

2012